H.I.S. Co., Ltd. Logo

H.I.S. Co., Ltd.

A major Japanese travel agency providing global tour packages, lodging, and transport.

9603 | T

Overview

Corporate Details

ISIN(s):
JP3160740001
LEI:
Country:
Japan
Address:
港区虎ノ門四丁目1番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

H.I.S. Co., Ltd. is a major Japanese travel agency established in 1980. The company initially distinguished itself by pioneering the sale of low-cost airline tickets in Japan. Its primary operations involve providing a wide range of travel services, including domestic and international tour packages, lodging, and transportation solutions. The H.I.S. Group has expanded its business portfolio to include hotel operations, regional revitalization projects, and specialized inbound tourism services. With a global network, it is recognized as one of Japan's leading travel organizations, catering to a diverse clientele worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-13 08:36
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-06-13 08:34
Interim Report
半期報告書-第45期(2024/11/01-2025/10/31)
Japanese 247.2 KB
2025-06-05 10:02
Regulatory News Service
臨時報告書
Japanese 19.6 KB
2025-05-23 08:31
Regulatory News Service
臨時報告書
Japanese 19.0 KB
2025-05-20 09:21
M&A Activity
臨時報告書
Japanese 19.7 KB
2025-04-30 08:32
Delisting Announcement
臨時報告書
Japanese 19.8 KB
2025-03-31 10:14
Legal Proceedings Report
臨時報告書
Japanese 21.7 KB
2025-03-31 10:05
Regulatory News Service
臨時報告書
Japanese 19.6 KB
2025-03-31 09:57
Governance Information
内部統制報告書-第44期(2023/11/01-2024/10/31)
Japanese 44.9 KB
2025-03-31 09:56
Registration Form
確認書
Japanese 8.1 KB
2025-03-31 09:55
Annual Report
有価証券報告書-第44期(2023/11/01-2024/10/31)
Japanese 2.1 MB
2025-03-31 09:40
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-03-31 09:39
Quarterly Report
訂正四半期報告書-第44期第2四半期(2024/02/01-2024/04/30)
Japanese 305.5 KB
2025-03-31 09:38
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-03-31 09:37
Quarterly Report
訂正四半期報告書-第44期第1四半期(2023/11/01-2024/01/31)
Japanese 249.1 KB

Automate Your Workflow. Get a real-time feed of all H.I.S. Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for H.I.S. Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for H.I.S. Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.